Practice Update
Malaria prophylaxis: recommendations for travellers
Travellers to malaria-endemic regions should seek guidance from their healthcare providers, including their pharmacist, on safe and effective strategies to prevent malaria. By Dr Sonal Patel BPharm, GCPH, PhD, MACP …
Never assume, even with electronic prescriptions
Without due attention, technological advances in health care can mean a heightened risk for pharmacists and patients, PDL warns In its latest practice alert, PDL shares information about avoiding errors …
Identifying complications of diabetes: the pharmacist’s role
This article discusses the various medical conditions that may occur more frequently with, or as a complication of diabetes. By Karalyn Huxhagen BPharm, FPS, FANZCAP (CommPharm, PrimCare), community pharmacist and …
Communication breakdowns and medication adherence
Breakdowns in communication can adversely affect a patient’s medication adherence. Fostering an open and continuous dialogue between patient and pharmacist will lead to improved medication adherence and better health outcomes. …
Vaccine hesitancy: nurturing confidence in vaccine hesitant consumers
As pharmacy’s vaccine role continues to expand, and as ambivalence about vaccination grows, pharmacists are increasingly confronting the problem of vaccine hesitancy. This article examines what drives this hesitancy and …
What pharmacists need to consider with urinary tract infections in people living with diabetes
This article highlights the pertinent intricacies of bacterial urinary tract infections in Australian adults with diabetes including pathophysiology, diagnostic and prognostic considerations, therapeutic management, prevention strategies, and the role of …
Clonidine compounding errors
PDL and the Australian Society of Compounding Pharmacists warn of serious errors involving compounding of clonidine suspension for children, including rare fatalities PDL is aware of multiple instances where a …